Market open
CollPlant Biotechnologies/$CLGN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CollPlant Biotechnologies
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
Ticker
$CLGN
Sector
Trading on
Industry
Biotechnology
Headquarters
Rehovot, Israel
Employees
57
ISIN
IL0004960188
Website
CLGN Metrics
BasicAdvanced
$21M
-
-$1.45
0.74
-
Price and volume
Market cap
$21M
Beta
0.74
52-week high
$3.70
52-week low
$1.81
Average daily volume
11K
Financial strength
Current ratio
4.438
Quick ratio
4.206
Long term debt to equity
16.896
Total debt to equity
22.882
Management effectiveness
Return on assets (TTM)
-40.81%
Return on equity (TTM)
-79.46%
Valuation
Price to revenue (TTM)
40.48
Price to book
1.55
Price to tangible book (TTM)
1.56
Price to free cash flow (TTM)
-1.43
Growth
Revenue change (TTM)
-95.30%
Earnings per share change (TTM)
135.29%
3-year revenue growth (CAGR)
-67.95%
3-year earnings per share growth (CAGR)
316.98%
CLGN News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for CollPlant Biotechnologies stock?
CollPlant Biotechnologies (CLGN) has a market cap of $21M as of May 09, 2025.
What is the P/E ratio for CollPlant Biotechnologies stock?
The price to earnings (P/E) ratio for CollPlant Biotechnologies (CLGN) stock is 0 as of May 09, 2025.
Does CollPlant Biotechnologies stock pay dividends?
No, CollPlant Biotechnologies (CLGN) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next CollPlant Biotechnologies dividend payment date?
CollPlant Biotechnologies (CLGN) stock does not pay dividends to its shareholders.
What is the beta indicator for CollPlant Biotechnologies?
CollPlant Biotechnologies (CLGN) has a beta rating of 0.74. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.